期刊文献+

我国特殊医学用途配方食品批准情况分析与开发建议 被引量:10

Approval Status Analysis of Formula Food for Special Medical Use in China and Its Development Proposal
下载PDF
导出
摘要 简述我国特医食品分类与注册管理制度,分析我国特医食品批准情况与开发难点。特医食品的开发建议首选不需要进行临床试验的全营养配方食品和非全营养配方食品;次选住院治疗病例多、营养不良发生比率高的肿瘤与肾病特定全营养配方食品;适时开发老年人全营养配方食品。针对发病率高、住院比例低的糖尿病与肥胖人群,建议开发辅助降血糖与减肥保健食品。 The classification and registration management system of formula food for special medical use(special medical food in short) in China are introduced in this paper, and the approval status and development difficulty of the special medical food are also analyzed. We propose that for the development of special medical food, the full nutrition formula food and non full nutrition formula food that need not undergo clinical trials are preferred;the specific full nutrition formula food for patients with tumor or kidney diseases of high hospitalization rate and high incidence of malnutrition is also proposed. The full nutrition formula food for the elderly should be developed in good time. For the people with diabetes and obesity of high incidence and low hospitalization rate, it is proposed to develop auxiliary hypoglycemic and weight reducing health foods.
作者 陈彬合 袁振海 贾婵媛 CHEN Bin-he;YUAN Zhen-hai;JIA Chan-yuan(Shandong Academy of Pharmaceutical Sciences,Jinan 250101,China)
出处 《食品与药品》 CAS 2020年第4期294-300,共7页 Food and Drug
关键词 特殊医学配方食品 注册管理 批准情况分析 开发建议 formula food for special medical use registration management approval status analysis development proposal
  • 相关文献

参考文献6

二级参考文献68

  • 1α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志,2005,21(7):421-424. 被引量:135
  • 2金惠敏,袁伟杰,叶志斌,等.肾脏病营养治疗学[M].北京:中国医药科技出版社,2000,22-34.
  • 3王梅.肾性病学[M].3版.北京:人民卫生出版社,2008:1908-1918.
  • 4Hruska KA, Mathew S, Lund R, et al. Hyperphospbelemia of chronic kidney disease [ J ]. Kidney Int ,2008,74 : 148 - 151.
  • 5谭琪,徐勇,沈蕾,姚仙.慢性肾病病人营养模式的研究[J].肠外与肠内营养,2007,14(6):356-358. 被引量:8
  • 6石汉平,江华,李薇,等,中国抗癌协会.中国肿瘤营养治疗指南[M].北京:人民卫生出版社,2015.
  • 7Chen W, Zheng R, Baade PD, et al. Cancer statistics in China. CACancer J Clin. 2016;66(2):115-132.
  • 8Guest JF, Panca M, Baeyens JP, et al. Health economic impactof managing patients following a community-based diagnosis ofmalnutrition in the UK. Clin Nutr. 2011;30(4):422-429.
  • 9Philipson TJ, Snider JT, Lakdawalla DN, et al. Impact of oralnutritional supplementation on hospital outcomes. Am J ManagCare. 2013;19(2):121-128.
  • 10Colomer R, Moreno-Nogueira JM, García-Luna PP, et al. N-3 fattyacids, cancer and cachexia: a systematic review of the literature. BrJ Nutr. 2007;97(5):823-831.

共引文献652

同被引文献117

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部